Gastroesophageal Reflux Disease (GERD) and Irritable Bowel Syndrome (IBS)—Is It One Disease or an Overlap of Two Disorders?
- 352 Downloads
Up to 79% of IBS patients report gastroesophageal reflux disease (GERD) symptoms, and up to 71% of GERD patients report irritable bowel syndrome (IBS) symptoms. There are two principal hypotheses for the common presence of IBS symptoms in GERD patients. The first theory suggests that GERD and IBS overlap in a significant number of patients. The second theory suggests that IBS-like symptoms are part of the spectrum of GERD manifestation. The first theory is supported by genetic studies and similarities in gastrointestinal sensory-motor abnormalities potentially due to general gastrointestinal disorder of smooth muscle or sensory afferents. The other theory is primarily supported by studies demonstrating improvement of IBS-like symptoms in GERD patients receiving anti-reflux treatment. The close relationship between GERD and IBS could be explained by either GERD affecting different levels of the GI tract or a high overlap rate between GERD and IBS due to similar underlying GI dysfunction.
KeywordsGastroesophageal reflux disease (GERD) Irritable bowel syndrome (IBS) Pathophysiologic mechanism Symptom assessment Visceral hyperalgesia
The authors wish to acknowledge the grant support from AstraZeneca, Eisai, TAP, and Vecta.
- 7.Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther. 2002;16:2081–2088. doi: 10.1046/j.1365-2036.2002.01377.x.
- 8.Talley NJ, Dennis EH, Schettler-Duncan V, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003;98:2454–2459. doi: 10.1111/j.1572-0241.2003.07699.x.PubMedCrossRefGoogle Scholar
- 19.Fass R, Stanghellini V, Monnikes H. Baseline analysis of symptom spectrum in GERD clinical trial patients: result from ReQuest database. Gastroenterology. 2006;130:A629.Google Scholar
- 39.Glatzel D, Abdel-Quader M, Gatz G, Pfaffenberger B. Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse. Digestion. 2007;75:69–78. doi: 10.1159/000101085.PubMedCrossRefGoogle Scholar
- 40.Monnikes H, Pfaffenberger B, Gatz G, Hein J, Bardhan KD. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole. Digestion. 2007;75:62–68.PubMedGoogle Scholar
- 41.Stanghellini V. ReQuest: new dimensions in the assessment and management of GERD. Drugs Today (Barc). 2005;41:7–11.Google Scholar